CoChat

Predominant Role of the 9-Hydroxy Metabolite of Risperidone in Elevating Blood Prolactin Levels

Knegtering, Rikus, Baselmans, Pepijn, Castelein, Stynke, Bosker, Fokko, Bruggeman, Richard, van den Bosch, Robert J. · 2005 · American Journal of Psychiatry
Cited by 150

The DOI matches its Crossref record.

Abstract

OBJECTIVE: The atypical antipsychotic risperidone significantly raises plasma prolactin levels in patients, but clozapine, olanzapine, and quetiapine do not. The differences in neuroendocrine response may be connected with the metabolism of the medications. The authors examined the contributory role of risperidone's active metabolite 9-hydroxy-risperidone by measuring plasma concentrations of risperidone, 9-hydroxy-risperidone, and prolactin. METHOD: Blood samples taken from 25 patients with psychotic disorders following 6 weeks of treatment with risperidone (mean dose=3 mg/day) were examined. Mean plasma concentrations of risperidone, 9-hydroxy-risperidone, and prolactin were 4.6, 19.4, and 49.3 ng/ml, respectively. RESULTS: The oral dose of risperidone correlated significantly with plasma concentrations of risperidone, 9-hydroxy-risperidone, active moiety, and prolactin. The plasma concentration of 9-hydroxy-risperidone, but not of risperidone, correlated significantly with increases in plasma prolactin. CONCLUSIONS: These data suggest that the 9-hydroxy metabolite plays a predominant role in risperidone's effect on prolactin release.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.162.5.1010

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 150

Metadata

Authors
Knegtering, R., Baselmans, P., Castelein, S., Bosker, F., Bruggeman, R., & van den Bosch, R. J.
Venue
American Journal of Psychiatry
Published
2005-05-01
Volume
162
Issue
5
Pages
1010-1012
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2108450329
Cited by
150
References
0
FWCI
8.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predominant Role of the 9-Hydroxy Metabolite of Risperidone in Elevating Blood Prolactin Levels. https://app.cochat.ai/papers/10.1176/appi.ajp.162.5.1010
The paper
Knegtering, R., Baselmans, P., Castelein, S., Bosker, F., Bruggeman, R., & van den Bosch, R. J. (2005). Predominant Role of the 9-Hydroxy Metabolite of Risperidone in Elevating Blood Prolactin Levels. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.162.5.1010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.